The patient experience of relapsed refractory multiple myeloma and perspectives on emerging therapies.
Crawford R, Gries KS, Valluri S, Fastenau J, Morrison R, Yeh TM, Olyslager Y, Goldberg JD, Schecter JM, Jackson CC, Deraedt W, Doward L.
Crawford R, et al.
Cancer Rep (Hoboken). 2022 Nov;5(11):e1603. doi: 10.1002/cnr2.1603. Epub 2022 Feb 15.
Cancer Rep (Hoboken). 2022.
PMID: 35168299
Free PMC article.